Pricing Log in Create free account

aTyr Pharma, Inc. (ATYR) vs Neuphoria Therapeutics Inc. (NEUP)

aTyr Pharma, Inc. and Neuphoria Therapeutics Inc. are both Biotechnology companies. aTyr Pharma, Inc. and Neuphoria Therapeutics Inc. are of similar size ($18.0M and $17.9M). Neuphoria Therapeutics Inc. grew revenue faster over the last twelve months: 3,535.1% against 6.78%. Across the 16 metrics below, Neuphoria Therapeutics Inc. leads on 10 and aTyr Pharma, Inc. on 6.

Valuation

Metric ATYR NEUP Biotechnology median
P/E n/m n/m 8.50
P/S 1.49 0.91 9.71
P/B 0.34 0.58 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.59 0.27 0.64
EV/Sales (3.37) (0.30) 9.21
Earnings yield (364.71%) (154.60%) (33.15%)
Free cash flow yield (328.74%) (85.14%) (25.50%)

Profitability

Metric ATYR NEUP Biotechnology median
Gross margin 1.72% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (98.67%) (61.70%) (56.36%)
Return on assets (70.97%) (46.95%) (48.04%)
Return on invested capital 0.00% (232.67%) 0.00%

Growth

Metric ATYR NEUP Biotechnology median
Revenue growth (TTM) 6.78% 3,535.05% 6.02%
EPS growth (last fiscal year) 6.98% (1,230.43%) 30.26%
Revenue growth, 5-year CAGR (14.75%) 19.07% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATYR NEUP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.12 27.85 4.72
Net debt to EBITDA 1.01 1.26 0.96

Dividend

Metric ATYR NEUP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ATYR NEUP Biotechnology median
Market cap 18.03m 17.91m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack